Stay updated on Sabatolimab in HMA for Higher Risk MDS Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.

Latest updates to the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page
- ChecktodayChange DetectedA new revision tag (v3.5.5) was added and the previous tag (v3.5.4) was removed. This updates the page’s version label in the history view to reflect the latest revision.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe history now includes a new revision entry for v3.5.4 and removes the previous v3.5.3. This updates the page's revision log to reflect the latest version.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision label on the page changed from v3.5.2 to v3.5.3, indicating a new release of the site. This metadata update does not alter the study record content or how the data is displayed.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision entry v3.5.2 is added and an older revision v3.5.0 is removed.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the Record History.SummaryDifference0.1%

- Check86 days agoChange DetectedAdded a new revision entry v3.4.3 and removed the previous entry v3.4.2 from the record history.SummaryDifference0.1%

Stay in the know with updates to Sabatolimab in HMA for Higher Risk MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.